Market Place
Sourcing Support
Takeda Ends Partnership With Veritas In Silico For mRNA-Targeting
15 Apr 2026 //
BIOSPACE
Takeda Ends mRNA Research Pact With Japanese Drug Discoverer
14 Apr 2026 //
FIERCE BIOTECH
Fda Proposes Budget; Takeda Terminates Partnership In Pharma
11 Apr 2026 //
ENDPOINTS NEWS
Takeda To Cut 634 US Jobs In Massive $1.3B Restructuring
30 Mar 2026 //
FIERCE PHARMA
Takeda Restructuring Will Affect Workforce, Could Include Layoffs
26 Mar 2026 //
BIOSPACE
Takeda Targets $1.3B In Savings With New Efficiency Drive
25 Mar 2026 //
FIERCE BIOTECH
SCOTUS Order Advances Racketeering Case Involving Takeda, Lilly
24 Mar 2026 //
FIERCE PHARMA
The Next Cambridge? LA Sets Its Sights Higher
12 Mar 2026 //
BIOSPACE
Lowey Notifies Payors of Amitiza Generics Class Action
09 Mar 2026 //
PR NEWSWIRE
Takeda consolidates Boston footprint
11 Feb 2026 //
FIERCE PHARMA
Takeda Looks To Put Generic Vyvanse Woes In The Rearview
30 Jan 2026 //
FIERCE PHARMA
Takeda Reports Third-Quarter FY2025 Results
29 Jan 2026 //
BUSINESSWIRE
Takeda Slashes US Headcount, Hitting Neuro Commercial Teams Hard
19 Jan 2026 //
BIOSPACE
Protagonist`s $400M JPM26 Decision Is Total No-Brainer
16 Jan 2026 //
BIOSPACE
Halozyme, Takeda Agreement To Develop Vedolizumab With ENHANZE
08 Jan 2026 //
PR NEWSWIRE
Takeda Shapes Future Clinical Research With Trial Representation
05 Jan 2026 //
BIOSPACE
XOMA Royalty, Takeda Strike Mezagitamab Royalty Deal
30 Dec 2025 //
GLOBENEWSWIRE
Beacon Biosignals Expands Collaboration With Takeda
19 Nov 2025 //
GLOBENEWSWIRE
Takeda Maintains FY2025 Plan Despite FX Impact And Pipeline
30 Oct 2025 //
BUSINESSWIRE
Nanoform Study Results To Be Presented At 2025 PODD Summit
21 Oct 2025 //
PHARMIWEB
Takeda Exits Cell Therapy, Dealing Blow To Promising Modality
02 Oct 2025 //
BIOSPACE
Takeda Plasma-Derived Therapies Team Conquers Mount Fuji
19 Sep 2025 //
FIERCE PHARMA
Takeda, VELA to Ship Meds Via First Wind-Powered Trimaran
16 Sep 2025 //
PHARMAWEB
Takeda to Ship Products Between Europe and U.S. via Cargo Vessels
16 Sep 2025 //
PRESS RELEASE
Nanoform Study Results to be Unveiled at US DDF Summit
11 Sep 2025 //
PHARMAWEB
Takeda Names Rhonda Pacheco as U.S. Business Unit President
11 Sep 2025 //
CONTRACTPHARMA
Takeda Reveals Ph3 Orexin Data for Narcolepsy at World Sleep 2025
08 Sep 2025 //
PHARMAWEB
Takeda Reports Q1 FY2025 Results, Late-Stage Pipeline Progress
30 Jul 2025 //
BUSINESSWIRE
Takeda Revenue Drops Due to Vyvanse Sales Issues
30 Jul 2025 //
FIERCE PHARMA
Chasing Takeda, Alkermes Reports Phase 2 Narcolepsy Win
21 Jul 2025 //
FIERCE BIOTECH
Takeda Establishes Lead in Narcolepsy Race With 2 Phase 3 Win
15 Jul 2025 //
BIOSPACE
Takeda Announces New Assignments of Directors
25 Jun 2025 //
BUSINESSWIRE
Takeda and Nature Call for Applications for 2026 Award
27 May 2025 //
BUSINESSWIRE
NEJM Publishes TAK-861 Phase 2b Narcolepsy Type 1 Trial Data
14 May 2025 //
BUSINESSWIRE
Takeda Announces FY2024 Results and FY2025 Outlook Showing Growth
08 May 2025 //
BUSINESSWIRE
Takeda to Invest $30B into U.S. Operations
08 May 2025 //
CONTRACTPHARMA
Protagonist, Takeda’s Rusfertide Ph 3 VERIFY Study Positive
03 Mar 2025 //
BUSINESSWIRE
Takeda Drops Epilepsy Drug, Names New CEO Amid Q3 Earnings
31 Jan 2025 //
BIOSPACE
Takeda Delivers Strong Q3 FY2024 Results
30 Jan 2025 //
BUSINESSWIRE
Julie Will Succeed Christophe Weber as CEO of Takeda in June 2026
30 Jan 2025 //
BUSINESSWIRE
Neurocrine Biosciences Amends Osavampator Collaboration with Takeda
27 Jan 2025 //
PR NEWSWIRE
Takeda discontinues gout med Uloric in US
25 Jan 2025 //
FIERCE PHARMA
Takeda launches innovation centre, eye to onboard AI-driven talent
20 Jan 2025 //
ECONOMICTIMES
Takeda touts 6 pipeline assets with big sales potential
16 Jan 2025 //
FIERCE PHARMA
Takeda casts a new line with first DTC ads for HyQvia in CIDP
16 Dec 2024 //
FIERCE PHARMA
Hutchmed to Receive Milestone Payment for FRUZAQLA® Reimbursement
12 Dec 2024 //
GLOBENEWSWIRE
Takeda Highlight Late-Stage Pipeline For Transformative Treatment
12 Dec 2024 //
BUSINESSWIRE
Teva to Divest Teva-Takeda Venture in Japan
05 Dec 2024 //
GLOBENEWSWIRE
Hutchmed Announces Launch by Takeda of FRUZAQLA in Japan
21 Nov 2024 //
GLOBENEWSWIRE
Takeda stops phase 2 post-anesthesia trial over slow enrollment
31 Oct 2024 //
FIERCE BIOTECH
HUTCHMED to Receive Milestone Payment for FRUZAQLA® Sales
31 Oct 2024 //
GLOBENEWSWIRE
Takeda Raises FY2024 Outlook After Strong First Half Results
31 Oct 2024 //
BUSINESSWIRE
Takeda And Boston Medical Center Collaborate On Decarbonization
24 Oct 2024 //
BUSINESSWIRE
After prior cuts, Takeda is laying off more staffers in MA
21 Oct 2024 //
FIERCE PHARMA
Joint Venture Established for Incubation of Drug Discovery Programs
08 Oct 2024 //
PR NEWSWIRE
HUTCHMED Announces Japan Approval For FRUZAQLA By Takeda
23 Sep 2024 //
GLOBENEWSWIRE
Takeda Provides $32M For Global CSR Partnerships
22 Sep 2024 //
BIOSPECTRUM ASIA
Takeda Commits $32M To Global CSR Health Partnerships
20 Sep 2024 //
PHARMABIZ
Takeda To Present Additional Data On TAK-861 For Narcolepsy
19 Sep 2024 //
BUSINESSWIRE
Lupin partners with Takeda to commercialise Vonoprazan
18 Sep 2024 //
EXPRESSPHARMA
